Vincent Nadeem
University of Toronto(CA)
Publications by Year
Research Areas
Monoclonal and Polyclonal Antibodies Research, Microtubule and mitosis dynamics, Protein Tyrosine Phosphatases, Fibroblast Growth Factor Research, T-cell and B-cell Immunology
Most-Cited Works
- → Carnitine palmitoyltransferase 1C promotes cell survival and tumor growth under conditions of metabolic stress(2011)495 cited
- → A molecular compendium of genes expressed in multiple myeloma(2002)186 cited
- → The Discovery of Polo-Like Kinase 4 Inhibitors: Identification of (1R,2S)-2-(3-((E)-4-(((cis)-2,6-Dimethylmorpholino)methyl)styryl)-1H-indazol-6-yl)-5′-methoxyspiro[cyclopropane-1,3′-indolin]-2′-one (CFI-400945) as a Potent, Orally Active Antitumor Agent(2014)168 cited
- → MIP-1α (CCL3) is a downstream target of FGFR3 and RAS-MAPK signaling in multiple myeloma(2006)79 cited
- → Discovery of inhibitors of the mitotic kinase TTK based on N-(3-(3-sulfamoylphenyl)-1H-indazol-5-yl)-acetamides and carboxamides(2014)38 cited
- → Optimizing Production of Antigens and Fabs in the Context of Generating Recombinant Antibodies to Human Proteins(2015)28 cited
- → Selection of recombinant anti‐SH3 domain antibodies by high‐throughput phage display(2015)15 cited
- → Abstract LB-215: Inhibition of Polo-like kinase 4 as an anti-cancer strategy(2011)7 cited
- → Macrophage Inflammatory Protein (MIP)-1alpha (CCL3) Is a Downstream Target of FGFR3 and RAS Signaling in Multiple Myeloma.(2005)2 cited
- Polycomb group protein Bmi1 regulates proliferation and senescence of breast cancer cells and is transcriptionally repressed by TP53.(2008)